Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $10.1650, but opened at $9.7380. Ambu A/S shares last traded at $9.70, with a volume of 300 shares traded.
Ambu A/S Stock Down 0.9%
The company has a current ratio of 2.92, a quick ratio of 1.73 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $2.28 billion, a price-to-earnings ratio of 34.64 and a beta of 0.98. The stock has a fifty day moving average of $10.24 and a 200-day moving average of $11.95.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $246.39 million for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Recommended Stories
- Five stocks we like better than Ambu A/S
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
- ERock IPO: A $1.3B Power Play Solution
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
